SEC Form 4 · accession 0001162194-15-000059
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert C Jones
Officer — EVP, RESEARCH & DEVELOPMENT
Period of report
Mar 12, 2015
Accepted (ET)
Mar 16, 2015 · 8:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Mar 12, 2015 | A | 4,800 | A | — | — | Common Stock | 4,800 | 4,800 | D |
| Employee Stock Option (Right to Buy)F3 | $41.14 | Mar 12, 2015 | A | 12,000 | A | — | Mar 12, 2025 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
- F24/48th of the total number of shares underlying the Restricted Stock Units granted will vest on May 20, 2015, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued employment through the applicable vest date.
- F32/48th of the shares subject to the Option vested on March 12, 2015 and 1/48th of the shares subject to the Option vest on April 1, 2015 and each month thereafter, such that the Option will be fully vested on January 1, 2019.